FPRX
Five Prime Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 1.77 Billion
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Website: http://www.fiveprime.com/
Shares Outstanding: 46.6 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1312 trading days
From: 2016-11-25 To: 2021-04-15
Lowest Point:
Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors
via: Business Wire at 2019-06-09 11:05:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the departure of Dr. Sheila Gujrathi from the companys board of directors. Dr. Gujrathi has … read more...
Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors
via: Business Wire at 2019-06-09 11:05:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the departure of Dr. Sheila Gujrathi from the companys board of directors. Dr. Gujrathi has … read more...
Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors
via: Business Wire at 2019-06-09 11:05:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the departure of Dr. Sheila Gujrathi from the companys board of directors. Dr. Gujrathi has … read more...
Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors
via: Business Wire at 2019-06-09 11:05:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the departure of Dr. Sheila Gujrathi from the companys board of directors. Dr. Gujrathi has … read more...
Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
via: Business Wire at 2019-06-09 11:00:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced thatAron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two i… read more...
Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
via: Business Wire at 2019-06-09 11:00:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced thatAron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two i… read more...
Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
via: Business Wire at 2019-06-09 11:00:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced thatAron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two i… read more...
Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
via: Business Wire at 2019-06-09 11:00:00:000
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced thatAron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two i… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|